Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharma symbols : Meip save search
MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients
Published: 2024-04-11 (Crawled : 21:00) - biospace.com/
MEIP | $3.3 1.54% 1.52% 26K
|
Health Technology
|
| O: 0.27%
H: 1.71%
C: -3.71%
me-344 avastin pharma cancer study
MEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344
Published: 2024-04-11 (Crawled : 21:00) - biospace.com/
MEIP | $3.3 1.54% 1.52% 26K
|
Health Technology
|
| O: 0.27%
H: 1.71%
C: -3.71%
me-344 pharma
MEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology Forum
Published: 2024-04-10 (Crawled : 12:30) - biospace.com/
MEIP | $3.3 1.54% 1.52% 26K
|
Health Technology
|
| O: 0.0%
H: 0.52%
C: -1.57%
pharma
MEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid Leukemia
Published: 2024-03-26 (Crawled : 19:00) - biospace.com/
MEIP | $3.3 1.54% 1.52% 26K
|
Health Technology
|
| O: -1.08%
H: 1.9%
C: 0.78%
pharma update leukemia study
MEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlights
Published: 2024-02-13 (Crawled : 23:00) - biospace.com/
MEIP | $3.3 1.54% 1.52% 26K
|
Health Technology
|
| O: -1.43%
H: 1.66%
C: -3.94%
pharma year results
MEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational Highlights
Published: 2023-11-09 (Crawled : 00:00) - biospace.com/
MEIP | $3.3 1.54% 1.52% 26K
|
Health Technology
|
| O: 0.42%
H: 2.21%
C: -2.62%
pharma year results
MEI Pharma to Present at the Stifel 2023 Healthcare Conference
Published: 2023-11-08 (Crawled : 14:30) - biospace.com/
MEIP | $3.3 1.54% 1.52% 26K
|
Health Technology
|
| O: -0.8%
H: 2.03%
C: -2.43%
pharma conference
MEI Pharma Announces Acceptance of Abstract for Presentation at ASH 2023
Published: 2023-11-02 (Crawled : 14:00) - biospace.com/
MEIP | $3.3 1.54% 1.52% 26K
|
Health Technology
|
| O: -0.71%
H: 0.84%
C: -1.0%
pharma presentation
MEI Pharma Adopts Limited-Duration Stockholder Rights Plan
Published: 2023-10-02 (Crawled : 11:00) - biospace.com/
MEIP | $3.3 1.54% 1.52% 26K
|
Health Technology
|
| O: -0.86%
H: 2.16%
C: 0.43%
pharma
MEI Pharma to Report 2023 Fiscal Year End Financial Results and Provide Corporate Overview on September 26, 2023
Published: 2023-09-21 (Crawled : 14:30) - biospace.com/
MEIP | $3.3 1.54% 1.52% 26K
|
Health Technology
|
| O: -5.92%
H: 13.78%
C: 12.59%
pharma report year financial results
MEI Pharma Announces First Patient Dosed in Clinical Study Evaluating ME-344 Plus Bevacizumab (AVASTIN®) in Patients with Previously Treated Metastatic Colorectal Cancer
Published: 2023-08-16 (Crawled : 13:00) - biospace.com/
MEIP | $3.3 1.54% 1.52% 26K
|
Health Technology
|
| O: 5.86%
H: 0.0%
C: -7.29%
me-344 avastin pharma cancer plus study
Infinity Pharmaceuticals Announces Termination of Merger Agreement with MEI Pharma
Published: 2023-07-24 (Crawled : 14:00) - biospace.com/
MEIP | $3.3 1.54% 1.52% 26K
|
Health Technology
|
| O: 0.13%
H: 0.0%
C: -2.83%
INFI | $0.016 12.5% 1.1M
|
Health Technology
|
| O: -35.88%
H: 9.39%
C: -7.27%
pharma pharmaceuticals agreement
MEI Pharma Reminds Shareholders to Vote Today FOR the Infinity Transaction
Published: 2023-07-19 (Crawled : 13:00) - biospace.com/
MEIP | $3.3 1.54% 1.52% 26K
|
Health Technology
|
| O: 1.48%
H: 0.95%
C: -2.12%
INFI | $0.016 12.5% 1.1M
|
Health Technology
|
| O: 0.83%
H: 2.04%
C: -0.34%
pharma today
Infinity Pharmaceuticals Announces Stockholder Approval of Merger with MEI Pharma
Published: 2023-07-14 (Crawled : 22:00) - biospace.com/
MEIP | $3.3 1.54% 1.52% 26K
|
Health Technology
|
| O: 1.93%
H: 9.01%
C: 8.14%
INFI | $0.016 12.5% 1.1M
|
Health Technology
|
| O: -0.51%
H: 2.65%
C: -14.37%
pharma approval pharmaceuticals
MEI Pharma Provides Final Reminder to Shareholders to Vote Today FOR the Merger With Infinity Pharmaceuticals
Published: 2023-07-11 (Crawled : 14:00) - biospace.com/
MEIP | $3.3 1.54% 1.52% 26K
|
Health Technology
|
| O: -0.76%
H: 1.53%
C: 0.15%
INFI | $0.016 12.5% 1.1M
|
Health Technology
|
| O: 2.13%
H: 1.04%
C: -4.17%
pharma pharmaceuticals today
MEI Pharma Reminds Shareholders to Vote FOR the Merger with Infinity Pharmaceuticals
Published: 2023-07-07 (Crawled : 14:00) - biospace.com/
MEIP | $3.3 1.54% 1.52% 26K
|
Health Technology
|
| O: -0.62%
H: 0.47%
C: 0.47%
INFI | $0.016 12.5% 1.1M
|
Health Technology
|
| O: 3.05%
H: 9.22%
C: 4.85%
pharma pharmaceuticals
MEI Pharma Highlights Recommendation by Leading Independent Proxy Advisory Firm ISS to Vote “FOR” Pending Transaction with Infinity Pharmaceuticals
Published: 2023-07-05 (Crawled : 13:00) - biospace.com/
MEIP | $3.3 1.54% 1.52% 26K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -1.96%
INFI | $0.016 12.5% 1.1M
|
Health Technology
|
| O: 5.43%
H: 0.0%
C: -7.01%
pharma pharmaceuticals
MEI Pharma Announces Planned Departure of CEO Daniel P. Gold, Ph.D. and Appointment of David M. Urso as Successor
Published: 2023-06-02 (Crawled : 13:00) - biospace.com/
MEIP | $3.3 1.54% 1.52% 26K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -0.66%
pharma ceo
MEI Pharma Announces Update of Ongoing Phase 1 Study Evaluating Oral CDK9 Inhibitor Voruciclib Alone and in Combination with Venetoclax in Patients with Acute Myeloid Leukemia or B-Cell Malignancies
Published: 2023-05-23 (Crawled : 13:00) - biospace.com/
MEIP | $3.3 1.54% 1.52% 26K
|
Health Technology
|
| O: 0.14%
H: 8.44%
C: 0.54%
pharma update ongoing leukemia study
MEI Pharma Reports Third Quarter Fiscal Year 2023 Results and Operational Highlights
Published: 2023-05-11 (Crawled : 00:00) - biospace.com/
MEIP | $3.3 1.54% 1.52% 26K
|
Health Technology
|
| O: 0.0%
H: 2.73%
C: -0.43%
pharma year results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.